As of mid-May, this variant has been identified in nearly 11% of sequenced samples reported worldwide. The WHO has designated this variant as a “variant under monitoring,” and currently assesses the ...

Odds of any acute cardiovascular event increased when compared with COVID-19 hospitalizations in boosted and unboosted individuals.

The announcement bypassed the usual review by the CDC’s Advisory Committee on Immunization Practices, a group that typically meets to review data and offer guidance on who should get a vaccine.

To assess the safety and efficacy of IV ibuprofen in older adults, researchers conducted a post hoc subgroup analysis with data from 4 prospective clinical studies.

ND0612 is an investigational drug-device therapy that provides a 24-hour continuous subcutaneous infusion of levodopa/carbidopa solution. The Food and Drug Administration (FDA) has accepted for review ...